Join our community of smart investors

QinetiQ profits in a sea of troubles

The Hampshire-based defence contractor has been pulling in the contracts both home and abroad.
May 26, 2017

As the market digested full-year figures for QinetiQ (QQ.), Donald Trump made use of a NATO meeting in Brussels to reiterate calls for other members of the defence alliance to step-up their spending commitments. When we upped our recommendation on the stock to buy last September, it was already clear that the imperative to increase national defence budgets was intensifying in the face of repeated terrorist outrages in Europe and escalating geo-political tensions globally. Eight months down the track and those dynamics are still very much in evidence, but these latest figures from the Hampshire-based defence contractor also demonstrate that the defence market is being driven by increasingly specialised demand, namely for "the type of niche, technology-driven products and test-and-evaluation expertise in which QinetiQ excels".

IC TIP: Buy at 311.8p

Full-year revenues ticked up slightly once positive currency translations were discounted, while underlying operating profits were up 7 per cent to £116m. Net capital expenditure increased through the period which, along with an increase in pension fund expense, meant that the underlying cash conversion rate fell to 68 per cent from 95 per cent at the March 2016 year-end. We believe this will be a temporary effect, particularly as the group pension scheme has moved into a £156m surplus from a deficit position a year earlier. This reversal, partly achieved through hedging strategies, is certainly at odds with the general deterioration in occupational funds since gilt yields headed south following the EU referendum. Even after forking out for acquisitions, including a deal to secure the target systems business of Meggitt (MGGT) for £57.5m, together with share buybacks and £33.4m in dividends, the group ended the period with a sizeable net cash position.

This is subscriber only content
Start your trial to keep reading
PRINT AND DIGITAL trial

Get 12 weeks for £12
  • Essential access to the website and app
  • Magazine delivered every week
  • Investment ideas, tools and analysis
Have an account? Sign in